| Indicators | Browse All

MiniMed Group, Inc. (MMED)

Healthcare | Medical Instruments & Supplies | Northridge, United States | NasdaqGS
17.37 USD +0.56 (3.331%) ⇧ (Oct. 15, 2026, 10:05 a.m. EDT)

Short-term:★★☆☆☆Long-term:★⯪☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 10:38 a.m. EDT

The investment case for MiniMed is currently fractured by severe execution risks and a lack of financial validation. Despite the company's ambitious goal to become a diabetes leader, the fundamentals tell a distress story: the business is burning cash with negative operating cash flow, negative profit margins, and a return on equity that is deeply negative. The balance sheet is fragile, with debt exceeding cash reserves, creating a precarious situation where the company must constantly raise capital to survive. This financial strain is likely the primary driver behind the sharp share price decline over the last year. The market's reaction is visible in the options chain, which screams caution. Traders are stacking up heavy put positions at strikes significantly above the current price, indicating a strong consensus that the stock could fall further. This defensive positioning contrasts sharply with the 'Buy' ratings from analysts, who appear to be betting on a turnaround that the current financial data does not yet support. With no dividend to provide income and a high risk of dilution from equity raises, the stock offers no safety net. Until the company demonstrates a path to profitability and stabilizes its balance sheet, the risk-reward profile remains skewed heavily toward the downside.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.095669
MSTL0.114548
AutoTheta0.125252
AutoETS0.125377

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 32%
H-stat 65.50
Ljung-Box p 0.000
Jarque-Bera p 0.046
Excess Kurtosis -0.25
Attribute Value
Sector Healthcare
Debt to Equity Ratio 1.63
Revenue per Share 12.221
Market Cap 4,887,048,192
Forward P/E 25.11
Profit Margins -9.74%
Website https://www.minimed.com

As of Oct. 10, 2026, 10:38 a.m. EDT: Speculators are aggressively positioning for downside protection, evidenced by massive open interest in out-of-the-money puts (strikes 25 and 30) compared to negligible call volume. While there is some call activity at strikes 25 and 30, the overwhelming capital allocation is in put writing or buying, suggesting a fear of a significant drop rather than a bet on a rally.


Info Dump

Attribute Value
52 Week Change -0.09085995
Address1 18,000 Devonshire Street
All Time High 24.43
All Time Low 10.65
Ask 21.31
Ask Size 2
Audit Risk 5
Average Analyst Rating 1.6 - Buy
Average Daily Volume10 Day 23,061,170
Average Daily Volume3 Month 5,244,540
Average Volume 5,244,540
Average Volume10Days 23,061,170
Bid 12.52
Bid Size 2
Board Risk 9
Book Value 12.873
City Northridge
Compensation As Of Epoch Date 1,798,675,200
Compensation Risk 4
Country United States
Crypto Tradeable 0
Currency USD
Current Price 17.37
Current Ratio 1.812
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 17.71
Day Low 16.6
Debt To Equity 1.63
Display Name MiniMed
Dividend Yield 0.0
Earnings Call Timestamp End 1,788,266,700
Earnings Call Timestamp Start 1,788,266,700
Earnings Timestamp 1,788,265,800
Earnings Timestamp End 1,794,832,200
Earnings Timestamp Start 1,794,832,200
Ebitda 286,000,000
Ebitda Margins 0.08876
Enterprise To Ebitda 16.019
Enterprise To Revenue 1.422
Enterprise Value 4,581,492,224
Eps Current Year 0.69578
Eps Forward 0.69177
Eps Trailing Twelve Months -1.4
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 20.4846
Fifty Day Average Change -3.1145992
Fifty Day Average Change Percent -0.15204589
Fifty Two Week Change Percent -9.085995
Fifty Two Week High 24.43
Fifty Two Week High Change -7.0599995
Fifty Two Week High Change Percent -0.28898892
Fifty Two Week Low 10.65
Fifty Two Week Low Change 6.720001
Fifty Two Week Low Change Percent 0.63098603
Fifty Two Week Range 10.65 - 24.43
Financial Currency USD
First Trade Date Milliseconds 1,772,807,400,000
Float Shares 28,466,986
Forward Eps 0.69177
Forward P E 25.109503
Full Exchange Name NasdaqGS
Full Time Employees 8,000
Fullday Change 0.5600014
Fullday Change Percent 3.3313587
Fullday Price 17.37
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.5689
Gross Profits 1,832,999,936
Has Pre Post Market Data 1
Held Percent Insiders 0.89942
Held Percent Institutions 0.13583
Implied Shares Outstanding 281,349,931
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Ipo Expected Date 2,026-03-06
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,776,988,800
Long Business Summary MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.
Long Name MiniMed Group, Inc.
Market us_market
Market Cap 4,887,048,192
Market State REGULAR
Max Age 86,400
Message Board Id finmb_1970346369
Most Recent Quarter 1,785,456,000
Net Income To Common -314,000,000
Next Fiscal Year End 1,808,524,800
Non Diluted Market Cap 5,770,487,084
Number Of Analyst Opinions 15
Open 16.6
Operating Cashflow -105,000,000
Operating Margins 0.0047400002
Overall Risk 7
Phone 763 514 4000
Previous Close 16.81
Price Eps Current Year 24.96479
Price Hint 2
Price To Book 1.3493359
Price To Sales Trailing12 Months 1.5167747
Profit Margins -0.097449996
Quick Ratio 1.265
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.625
Region US
Regular Market Change 0.5600014
Regular Market Change Percent 3.3313587
Regular Market Day High 17.71
Regular Market Day Low 16.6
Regular Market Day Range 16.6 - 17.71
Regular Market Open 16.6
Regular Market Previous Close 16.81
Regular Market Price 17.37
Regular Market Time 1,792,073,114
Regular Market Volume 2,864,642
Return On Equity -0.086619996
Revenue Growth 0.166
Revenue Per Share 12.221
Sand P52 Week Change 0.16440773
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 281,349,931
Shares Percent Shares Out 0.0647
Shares Short 18,197,982
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 8,060,409
Short Name MiniMed Group, Inc.
Short Percent Of Float 0.6377
Short Ratio 6.07
Source Interval 15
State CA
Symbol MMED
Target High Price 30.0
Target Low Price 15.0
Target Mean Price 25.0
Target Median Price 26.0
Total Cash 207,000,000
Total Cash Per Share 0.736
Total Debt 59,000,000
Total Revenue 3,222,000,128
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.4
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 16.465454
Two Hundred Day Average Change 0.90454674
Two Hundred Day Average Change Percent 0.054936033
Type Disp Equity
Volume 2,839,380
Website https://www.minimed.com
Zip 91,325